Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.24 USD | -0.88% | -1.74% | -11.76% |
05-23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
05-23 | CRISPR Therapeutics Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.76% | 4.73B | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Morgan Stanley Lifts Price Target on CRISPR Therapeutics to $46 From $42, Keeps Underweight Rating